Loading...
•
Dec 31, 2023
Bruker Q4 2023 Earnings Report
Bruker's Q4 2023 performance showcased strong revenue growth, driven by organic expansion and strategic acquisitions, though non-GAAP EPS experienced a slight decline.
Key Takeaways
Bruker reported Q4 2023 revenues of $854.5 million, a 20.6% increase year-over-year, with organic revenue up by 15.9%. GAAP EPS was $1.41, including a gain from the PhenomeX acquisition, while non-GAAP EPS was $0.70, a 5.4% decrease year-over-year. The company's full-year revenue reached $2.96 billion, with a 17.1% increase year-over-year and organic revenue growth of 14.5%.
Q4 2023 revenues increased by 20.6% year-over-year, reaching $854.5 million, with organic revenue growth of 15.9%.
GAAP EPS for Q4 2023 was $1.41, which included a $0.99 gain per share from the PhenomeX acquisition.
Non-GAAP EPS for Q4 2023 decreased by 5.4% year-over-year to $0.70, but pro forma non-GAAP EPS, excluding the PhenomeX acquisition, increased by 8.1%.
Full-year 2023 revenues grew by 17.1% to $2.96 billion, with organic revenue growth of 14.5%.
Bruker
Bruker
Bruker Revenue by Segment
Bruker Revenue by Geographic Location
Revenue by Segment
BEST Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.com Forward Guidance
Bruker expects FY 2024 revenues of $3.23 to $3.29 billion, or 9% to 11% yoy reported revenue growth, including yoy contributions from organic revenue growth of 5% to 7%. Bruker expects FY 2024 non-GAAP EPS of $2.71 to $2.76, or 5% to 7% growth yoy.
Positive Outlook
- Organic revenue growth of 5% to 7%
- Constant exchange rate (CER) revenue growth of 8% to 10%, with M&A contributions of ~3%
- Foreign currency translation tailwind of ~1%
- Revenue between $3.23B and $3.29B
- Non-GAAP EPS growth of 5% to 7%